C51H 38 Cl 2 F 2 N 6 O14S 2 , triclinic, P1 (no. 2), a = 11.8987 (6) Å, b = 14.0939(8) Å, c = 16.1915(9) Å, α = 67.590(5)°, β = 75.402(5)°, γ = 77.522(4)°, V = 2407.3(2) Å 3 , Z = 2, Rgt(F) = 0.0584, wR ref (F 2 ) = 0.1645, T = 100.0(1) K.
CrysAlis PRO [1] , SHELX [2, 3] were added to a solution with 25 mL acetic acid. Dry HCL gas was passed through the solution about 25 min.
After stirring at room temperature overnight, the mixture produced a precipitate. The precipitate was filtered and washed by acetone to get a yellow intermediate. Then, the intermediate, 4 -fluorobenzenesulfonylchloride (0.62 g, 5.0 mol) and potassium carbonate (2.76 g, 0.02 mol) were added to 50 mL of dichloromethane. The mixture was stirred for about 12 h at room temperature. The precipitate was collected, washed with water and recrystallized from dichloromethane/methanol (2:3, v/v) to get light yellow crystals of the title compound.
Experimental details
All H atoms were placed in idealized positions and treated as riding on their parent atoms, with d(C-H) = 0.97 Å (methylene), U iso (H) = 1.2Ueq(C) and d(C-H) = 0.93 Å (aromatic),
Comment
Curcumin, is a yellow pigment extracted from the rhizome of turmeric, which has been extensively investigated for its antitumor, anti-inflammatory activity, anti-oxidation and other activities. However, its clinical application was limited due to its poor aqueous solubility, relatively low bioactivities and bioavailability [4] . In order to improve these weakness, many curcumin analogs were previously synthesized as better antitumor and anti-inflammatory agents, such as 3E,5E)-3,5-bis(arylidene)-4-piperidones (BAPs) [5, 6] . In our previous study, we found BAPs have greater predilection or sequential interaction for bio-thiols resulting in a greater activity to tumors rather than with normal cells [7] . In order to improve its biological activity, strong electronwithdrawing substituent groups (Such as -NO 2 , -CN, -CF 3 ) were introduced on both sides of BAPs. While some electronwithdrawing trifluoromethyl groups (Such as -F, -NO 2 , -CN, -CF 3 ) were introduced into N-benzenesulfonyl substituents of BAPs. By introducing these groups, the antitumor and antiinflammatory activity of BAPs should be improved, while toxicity should be reduced to different degrees [8] .
Crystal structure and bioactivity of 4-((E)-((E)-5-(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)-4oxopiperidin-3-ylidene)methyl)benzonitrile (BAP-1) and (3E, 5E)-3,5-bis(4-cyanobenzylidene)-1-((4-fluorophenyl)sulfonyl) piperidin-4-one (BAP-2) were reported by our group [9, 10] . Recently, we found that the antitumor and anti-inflammatory activity were improved when fluorine was substituted on N-benzenesulfonyl substituents of BAPs. Herein, the crystal structure of (3E,5E)-1-((4-fluorophenyl)sulfonyl)-3,5-bis(3nitrobenzylidene)piperidin-4-one-dichloromethane(2/1) will be reported.
There are two BAP molecules and a dichloromethane molecule in the asymmetric unit of the title compound (cf. the figure). Bond lengths and angles are all in the expected ranges. Single-crystal structure analysis reveals that configurations of the two BAPs molecules are different. In a molecule, two 3-nitro phenyl groups on both sides of BAP take the trans-configuration compared with the central piperidin-4-one. And the two 3-nitro phenyl groups adopt the E stereochemistry of olefinic double bonds, which was the same as those reported in literature [10] . In the other molecule, two 3-nitro phenyl groups are symmetric compared with central piperidin-4-one, which also adopt the E stereochemistry of the double bond. The dihedral angles between two 4-nitro phenyl groups in both molecules are 32.61(6)°and 26.36(3)°, respectively. Interestingly, the 4trifluoromethylphenyl group bend towards the side of carbonyl group in one molecule, which looks like an "organic clip" [10] , however, 4-trifluoromethylphenyl group stretch in the other direction of carbonyl group in another molecule. The peripheric heteroatoms (Such as F, N, O, S) can act as hydrogen bonding acceptors for bioactive molecules with the aim of creating more potent biological activity [11, 12] .
